Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Boehringer Ingelheim divulges SLC13A5 inhibitors

July 6, 2018

Serum netrin-1, a potential early biomarker for impaired fasting glucose and type 2 diabetes

July 6, 2018

CB-4211 potentiates insulin effects on fatty acid metabolism and glucose homeostasis

July 6, 2018

Mitsubishi Tanabe studies MT-7117 in phase II for erythropoietic protoporphyria

July 5, 2018

Conserved haplotype in SGLT1 is linked with lower risk of dietary hyperglycemia

July 5, 2018

Clinical trial authorization granted in U.K. for phase I study of FOR-6219

July 5, 2018

JCR initiates phase III trial of JR-401X for SHOX deficiency

July 4, 2018

Merck & Co. presents FFA1 receptor agonists

July 3, 2018

NovaTarg divulges new AMPK activators for diabetes

July 3, 2018

FDA grants fast track designation to CUTX-101 for treatment of classic Menkes disease

July 3, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...